Castle Biosciences, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
478 | 57.21 | 735.49% | -20.53 | -2 428.12% |
| P/S |
|
2.67 | 33.44 | -92% |
|
|
| P/BV |
|
1.5 | 4.65 | -67.68% |
|
|
| P/FCF |
|
-24.85 | 42.56 | -158.4% |
|
|
| Ev/Ebitda |
|
-9.06 | -17.68 | -48.74% |
|
|
| Ev/S |
|
2.29 | 22.52 | -89.81% |
|
|
| Ev/FCF |
|
-36.66 | 47.58 | -177.03% |
|
|
| E/P |
|
-0.1681 | 0.0188 | -994.02% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-25.32 | -13.3 | 90.37% | -27.28 | -7.18% |
| ROE |
|
-14.69 | 9.69 | -251.56% |
|
|
| ROA |
|
-12.03 | 0.2896 | -4252.89% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-26.15 | -25.08 | 4.28% |
|
|
| ROCE |
|
-17.37 | 14.58 | -219.18% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.2751 | -3.62 | -92.4% | -0.2679 | +2.68% |
| Nеt Debt/Ebitda |
|
1.5 | -4.05 | -137.05% |
|
|
| Debt/Ratio |
|
0.032 | 0.1841 | -82.6% |
|
|
| Debt/Equity |
|
0.0524 | 1.6 | -96.72% |
|
|
| Debt/Net Income |
|
-0.2664 | 0.9168 | -129.06% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5448 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4954 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5448 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
323.77 | 31.71 | 921.03% | ||
| Growth impulse Ebitda in 5 years |
|
-988.92 | -23.28 | 4147.94% | ||
| Growth impulse Net Income in 5 years |
|
-1188.99 | -61.56 | 1831.43% | ||
| Growth impulse FCF in 5 years |
|
-416.67 | -26 | 1502.58% | ||
| Growth impulse EPS in 5 years |
|
-451.78 | -63.63 | 610.01% |
IP Score
3.16/10
